Further delving into ARA-290's potential mode of action, it is believed to engage the EPOR-cR complex, apparently initiating a cascade of signaling events
Beyond GLP-1s, AbbVies immunology bet on Skyrizi is paying off: the IL-23 inhibitor posted over 60% growth in both quarters on expanded use in inflammatory bowel disease and ongoing strength in psoriasis
In past, computational methods for predicting half-life of proteins/peptides in blood and kidney cells/cell lines have been developed
HE staining results indicated that prenatal fullerenols exposure caused thinning of the placental villous layer, cell shrinkage, serious cell vacuolization, decreased tight junctions between cells and a slight increase in some local intercellular gaps (Fig
Book a doctor assessment to check your eligibility for GLP-1 therapy
Traumatic brain injury and risk of dementia in older veterans